0001441844-11-000041.txt : 20111004
0001441844-11-000041.hdr.sgml : 20111004
20111004172047
ACCESSION NUMBER: 0001441844-11-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111003
FILED AS OF DATE: 20111004
DATE AS OF CHANGE: 20111004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baker Mark Robert
CENTRAL INDEX KEY: 0001331438
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 111124776
MAIL ADDRESS:
STREET 1: 120 STATE STREET
CITY: BROOKLYN
STATE: NY
ZIP: 11201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9147892800
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2011-10-03
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001331438
Baker Mark Robert
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
CEO
Common Stock
2011-10-03
4
M
0
5124
4.624
A
42345
D
Common Stock
2011-10-03
4
F
0
4666
5.44
D
37679
D
ESPP (right to buy)
4.624
2011-10-03
4
M
0
5124
0
D
2011-10-01
2011-10-01
Common Stock
5124
0
D
Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
By: Robert A. McKinney For: Mark R. Baker
2011-10-04